FDA Inspection
Teva Pharmaceuticals USA, IncTeva Pharmaceuticals USA, Inc – FDA Inspection, Aug 14, 2009
Record Details
This FDA Inspection record concerns Teva Pharmaceuticals USA, Inc, with an inspection on August 14, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 14, 2009
- Product Type
- Drugs
View Company Profile
ID · 321f7dad-6379-49aa-ba41-ffdddcfdb322
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 600741
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Teva Pharmaceuticals USA, Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 9, 2025 | Not classified | New Jersey District Office | |
| September 29, 2023 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 16, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 2, 2010 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| March 1, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Teva Pharmaceuticals USA, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.